← Insider buys
KITE

Kite Pharma, Inc.

Director Owen N. Witte sold $2.5M of Kite Pharma, Inc.

Sold$2,507,500
$100.30Price
25,000Shares
−25%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Fri, Jun 23. Filed Mon, Jun 26, 3:55 PM ET, during the session. Not investment advice.